Related Experiment Video
Updated: Jun 22, 2026

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024
[Hepatitis C recurrence after living donor and cadaveric liver transplantation]
Júlio Cezar Uili Coelho1, Luciano Okawa, Mônica Beatriz Parolin
1Serviço de Cirurgia do Aparelho Digestivo e Transplante Hepático do Hospital de Clínicas da Universidade Federal do Paraná, Curitiba, PR. coelhojcu@yahoo.com.br
Insights
Hepatitis C recurrence rates are comparable between living donor liver transplantation and cadaveric liver transplantation. This study found no significant difference in post-transplant hepatitis C virus recurrence between the two liver transplant methods.
Area of Science:
- Hepatology
- Transplant Surgery
- Virology
Context:
- Hepatitis C virus (HCV) infection is a leading cause of liver cirrhosis and end-stage liver disease.
- Liver transplantation is a definitive treatment for end-stage liver disease due to HCV.
- Both living donor liver transplantation (LDLT) and cadaveric donor liver transplantation (CDLT) are established procedures for HCV patients.
Purpose:
- To compare the recurrence rates of hepatitis C virus infection after living donor liver transplantation versus cadaveric liver transplantation.
- To evaluate the impact of donor type on post-transplant HCV outcomes.
- To analyze factors influencing HCV recurrence in liver transplant recipients.
Summary:
- A study of 55 CDLT and 10 LDLT recipients with HCV-related cirrhosis found similar baseline characteristics, except for prothrombin time.
- Hepatitis C virus recurrence rates were comparable between CDLT (69.3%) and LDLT (70%) groups (P=0.8).
- Acute rejection rates were also similar between CDLT (49%) and LDLT (20%) groups (P=0.08).
Impact:
- Provides crucial data for clinicians and patients regarding donor selection for liver transplantation in HCV-infected individuals.
- Suggests that donor type may not significantly influence hepatitis C recurrence post-transplantation.
- Contributes to the understanding of long-term outcomes in liver transplant recipients with viral hepatitis.
Objective:
To determine the recurrence of hepatitis C in patients subjected to living donor liver transplantation compared to those subjected to cadaveric liver transplantation.
Methods:
Of a total of 333 liver transplantations, 279 (83.8%) were cadaveric liver transplantation and 54 (16.2%) living donor liver transplantation. Hepatic cirrhosis due to hepatitis C virus was the most common indication of both cadaveric liver transplantation (82 patients) and living donor liver transplantation (19 patients). The electronic study protocols of all patients with hepatic cirrhosis due to hepatitis C virus were reviewed. All data, including patients' age and sex, laboratory tests, hepatitis C virus recurrence and acute rejection were evaluated statistically.
Results:
A total of 55 cadaveric liver transplantation and 10 living donor liver transplantation performed in patients with liver cirrhosis due to hepatitis C virus was included in the study. Clinical and laboratory characteristics of the two groups before the transplantation were similar, except for the prothrombin time that was higher for the cadaveric liver transplantation than the living donor liver transplantation (P = 0.04). Hepatitis C virus recurrence was similar in the cadaveric liver transplantation (n = 37; 69.3%) and living donor liver transplantation (n = 7; 70%) groups (P = 0.8). The incidence of acute rejection was similar in cadaveric liver transplantation (n = 27; 49%) and living donor liver transplantation (n = 2; 20%) groups (P = 0.08). Hepatitis C virus recurrence in patients of the cadaveric liver transplantation group who received bolus doses of corticosteroids (9 of 11 patients) was similar to the remained patients (28 of 44 patients) (P = 0.25). Recurrence was also similar in patients of the living donor liver transplantation group who received bolus doses of corticosteroids (one of one patient) in relation to those who did not receive them (six of nine patients) (P = 0.7).
Conclusion:
Hepatitis C recurrence is similar in patients who underwent living donor liver transplantation or cadaveric liver transplantation.
Related Concept Videos
Hepatitis
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
